Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperpnea and Hyperventilation01:25

Hyperpnea and Hyperventilation

Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term health outcomes in patients with Prader-Willi Syndrome: a nationwide cohort study in Denmark.

International journal of obesity (2005)·2017
Same author

Gatemon Benchmarking and Two-Qubit Operations.

Physical review letters·2016
Same author

Atrial fibrillation and stroke in adult patients with atrial septal defect and the long-term effect of closure.

Heart (British Cardiac Society)·2015
Same author

Delayed sidetone in relation to the reading of different materials.

Journal of psycholinguistic research·2013
Same author

INFANTILE METACHROMATIC LEUCODYSTROPHY.

Journal of neurology, neurosurgery, and psychiatry·2011
Same author

Comparison of some properties of pronethalol and propranolol. 1965.

British journal of pharmacology·2010

Related Experiment Video

Updated: Jul 16, 2026

Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury
09:16

Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury

Published on: February 26, 2017

Respiratory failure precipitated by high carbohydrate loads.

H D Covelli, J W Black, M S Olsen

    Annals of Internal Medicine
    |November 1, 1981
    PubMed
    Summary

    High carbohydrate loads in total parenteral nutrition can cause acute respiratory failure. This occurs when the body produces too much carbon dioxide, overwhelming limited ventilation capacity.

    Area of Science:

    • Metabolism
    • Respiratory Physiology
    • Clinical Nutrition

    Background:

    • Total parenteral nutrition (TPN) is a method of feeding that bypasses the gastrointestinal tract.
    • Nutritional support is critical for patients unable to eat normally.
    • Carbohydrates are a primary energy source in TPN regimens.

    Observation:

    • Three patients requiring ventilatory support developed acute respiratory failure shortly after initiating TPN.
    • The TPN solutions administered were high in carbohydrate content.
    • Patients exhibited signs of respiratory distress and hypercapnia.

    Findings:

    • High carbohydrate loads in TPN increase carbon dioxide (CO2) production.
    • This increased CO2 production can lead to respiratory acidosis in patients with compromised ventilation.

    More Related Videos

    Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
    06:22

    Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)

    Published on: April 7, 2021

    A Porcine Model of Acute Respiratory Failure with a Continuous Infusion of Oleic Acid
    04:10

    A Porcine Model of Acute Respiratory Failure with a Continuous Infusion of Oleic Acid

    Published on: March 8, 2024

    Related Experiment Videos

    Last Updated: Jul 16, 2026

    Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury
    09:16

    Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury

    Published on: February 26, 2017

    Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
    06:22

    Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)

    Published on: April 7, 2021

    A Porcine Model of Acute Respiratory Failure with a Continuous Infusion of Oleic Acid
    04:10

    A Porcine Model of Acute Respiratory Failure with a Continuous Infusion of Oleic Acid

    Published on: March 8, 2024

  • The respiratory quotient (RQ) significantly increased, indicating a shift towards carbohydrate metabolism.
  • Implications:

    • Excessive carbohydrate administration in TPN may precipitate respiratory complications.
    • Careful monitoring of respiratory function is crucial in patients receiving high-carbohydrate TPN.
    • Individualizing TPN composition may be necessary to prevent adverse respiratory outcomes.